Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
The scientists have been sceptic over the rationale for prolonged corticosteroid treatment in the Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19....
Easily correctable condition of Vitamin D Insufficiency (VDI) has very severe implications for COVID-19. In countries worst affected by COVID-19 such as Italy, Spain and Greece, Vitamin D insufficiency (VDI) rates were high in the range of 70-90%.; on...
A biotech firm, Moderna, Inc. has announced that ‘mRNA-1273’, their mRNA vaccine against novel coronavirus has shown positive results in the phase 1 clinical trials
In the race for the development of vaccines for the treatment of COVID-19, Moderna Inc.,...
Clinical Trials to evaluate effectiveness of anti-malarial drug, hydroxychloroquine (HCQ) and antibiotic, Azithromycin in treating older people with COVID-19 begins in the UK and USA with an aim to reducing the severity of symptoms and avoiding hospitalization
Of late, there...
Several studies indicate that activation of NLRP3 inflammasome is responsible for acute respiratory distress syndrome and/or acute lung injury (ARDS/ALI) seen in severely ill COVID-19 patients which often result in death due to multiple organ failure. This suggests NLRP3...
Humans would not have existed without viruses because viral protein plays a key role in the development of human embryo. However, at times, they pose existential threats in the form of diseases as in the case of current COVID-19...
A combination of biological and computational approach to study protein-protein interactions (PPIs) between the viral and the host proteins in order to identify and repurpose drugs for an effective treatment of COVID-19 and possibly other infections as well
The usual...
The European Commission has launched www.Covid19DataPortal.org where the researchers can store and rapidly share datasets. The rapid sharing of relevant data would accelerate research and discovery.
With an aim to support researchers by enabling rapid collection and sharing of available research data,...
The infection fatality rate (IFR) is more reliable indicator of the extent of the infection. In this study, the researchers found the actual infection rate for COVID-19 in Heinsberg to be five-fold higher than the number officially reported using...
Social interaction and vaccination both contribute to development of herd immunity however development of herd immunity as a result of social interaction is directly proportional to the number of secondary infections that arise from the primary cases. Herd immunity...
The recently completed UK-wide, ISARIC Study on analysis of 16749 patients with severe COVID-19 disease across 166 hospitals indicated that those with co-morbidity were at much higher risks while those with no significant comorbidity come out alive suggesting people...
For quicker lifting of lockdown, the innovators or entrepreneurs holding IP rights over novel technologies with potential to improve diagnostics and therapeutics for COVID-19, who may otherwise be unable to launch the products at scaled up level due to...
Convalescent plasma therapy holds key for the immediate treatment of severely sick COVID-19 patients. This article discusses effectiveness of this therapy and its present status about its use in treating COVID-19
The COVID-19 disease has engulfed the entire world with...
Development of vaccine for COVID-19 is a global priority. In this article, the author has reviewed and evaluated research and development and the present status of vaccine development.
COVID-19 disease, caused by SARS-CoV-2 virus, has been steadily increasing in the...
Laboratory tests for diagnosis of COVID-19 currently in practice as advised by the international bodies of experts are reviewed and evaluated.
The COVID-19 disease, that originated in Wuhan China, has affected more than 208 countries till now. The scientific community...
Use of nasal gel as a novel means to inactivate COVID-19 in a biological manner and prevent its entry into human body may help avert community transmission of this virus, thereby helping in disease control and management.
In an effort...
The containment scheme based on 'quarantine' or 'social distancing' has emerged as the main tool in fight against COVID-19. But, there are concerns about economic and psychological costs. A researcher offers ''social containment'' as an alternative which seems to...
WHO doesn't recommend face masks generally to the healthy people. However, CDC has now laid down new guideline and say ''people should wear cloth masks when they go outside''. New evidence suggest that the usage of surgical face masks...
The disease caused by the novel coronavirus (2019-nCoV) has been given new name COVID-19 by the international body WHO which makes no reference to any of the people, places or animals associated with this virus.
The disease caused by the...
